Provider of medical cannabis testing and analytics service designed to measure the potency and safety of all cannabinoid infused products and medicines. The company's services use premium instruments and qualified methodologies to quantify up to 20 cannabinoids, as many as 42 terpenes, microbiological/pesticide contaminants and residual solvents, enabling cannabis cultivators to improve their product.
Generating Revenue
Privately Held (backing)
Venture Capital-Backed
The company raised an undisclosed amount of venture funding from Merida Capital Partners on August 27, 2018. Previously, the company raised $2.5 million of Series 3 venture funding from Gotham Green Partners and Slifka Asset Management on November 13, 2017. Merida Capital Partners also participated in the round.
Add a review